These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 29791488

  • 21. Factors predicting sputum smear conversion and treatment outcomes in new smear-positive pulmonary tuberculosis.
    Unsematham S, Kateruttanakul P.
    J Med Assoc Thai; 2013 Jun; 96(6):644-9. PubMed ID: 23951819
    [Abstract] [Full Text] [Related]

  • 22. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Abebe M, Atnafu A, Tilahun M, Sero N, Neway S, Alemu M, Tesfaye G, Mihret A, Bobosha K, Wan C.
    PLoS One; 2024 Jun; 19(5):e0304507. PubMed ID: 38820260
    [Abstract] [Full Text] [Related]

  • 23. Development of a risk score for prediction of poor treatment outcomes among patients with multidrug-resistant tuberculosis.
    Alene KA, Viney K, Gray DJ, McBryde ES, Xu Z, Clements ACA.
    PLoS One; 2020 Jun; 15(1):e0227100. PubMed ID: 31899769
    [Abstract] [Full Text] [Related]

  • 24. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H.
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [Abstract] [Full Text] [Related]

  • 25. Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB.
    Chien JY, Chen YT, Shu CC, Lee JJ, Wang JY, Yu CJ, Yang PC.
    Chest; 2013 Jun; 143(6):1725-1732. PubMed ID: 23288018
    [Abstract] [Full Text] [Related]

  • 26. Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Velayutham B, Nair D, Kannan T, Padmapriyadarsini C, Sachdeva KS, Bency J, Klinton JS, Haldar S, Khanna A, Jayasankar S, Swaminathan S.
    Int J Tuberc Lung Dis; 2016 Dec; 20(12):1671-1676. PubMed ID: 27931345
    [Abstract] [Full Text] [Related]

  • 27. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J, Lee BJ, Yoon HI, Lee CT, Lee JH.
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [Abstract] [Full Text] [Related]

  • 28. Linezolid in the treatment of MDR-TB: a retrospective clinical study.
    Xu HB, Jiang RH, Li L, Xiao HP.
    Int J Tuberc Lung Dis; 2012 Oct; 16(3):358-63. PubMed ID: 22640450
    [Abstract] [Full Text] [Related]

  • 29. Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China.
    Chen Q, He W, Du J, Kang W, Zou L, Tang X, Tang P, Guo C, Pan Q, Zhu Q, Yang S, Guo Z, Wu G, Tang S.
    Antimicrob Resist Infect Control; 2024 Oct 15; 13(1):126. PubMed ID: 39407338
    [Abstract] [Full Text] [Related]

  • 30. Time to detection in liquid culture of sputum in pulmonary MDR-TB does not predict culture conversion for early discharge.
    Rieu R, Chang C, Collin SM, Fazekas J, Dassanaike S, Abbara A, Davidson RN.
    J Antimicrob Chemother; 2016 Mar 15; 71(3):803-6. PubMed ID: 26661394
    [Abstract] [Full Text] [Related]

  • 31. Predictors of delayed culture conversion in patients treated for multidrug-resistant tuberculosis in Pakistan.
    Qazi F, Khan U, Khowaja S, Javaid M, Ahmed A, Salahuddin N, Hussain H, Becerra MC, Golub JE, Khan AJ.
    Int J Tuberc Lung Dis; 2011 Nov 15; 15(11):1556-9, i. PubMed ID: 22008773
    [Abstract] [Full Text] [Related]

  • 32. Risk and outcome of multidrug-resistant tuberculosis: vitamin D receptor polymorphisms and serum 25(OH)D.
    Rathored J, Sharma SK, Singh B, Banavaliker JN, Sreenivas V, Srivastava AK, Mohan A, Sachan A, Harinarayan CV, Goswami R.
    Int J Tuberc Lung Dis; 2012 Nov 15; 16(11):1522-8. PubMed ID: 22990231
    [Abstract] [Full Text] [Related]

  • 33. MTBDRplus results correlate with treatment outcome in previously treated tuberculosis patients.
    Huang FL, Jin JL, Chen S, Zhou Z, Diao N, Huang HQ, Liu W, Wang Q, Weng XH, Chaisson RE, Zhang Y, Zhang WH.
    Int J Tuberc Lung Dis; 2015 Mar 15; 19(3):319-25, i-ii. PubMed ID: 25686141
    [Abstract] [Full Text] [Related]

  • 34. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
    Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ.
    Int J Tuberc Lung Dis; 2011 Oct 15; 15(10):1315-22. PubMed ID: 22283887
    [Abstract] [Full Text] [Related]

  • 35. Sputum smear conversion and associated factors among smear-positive pulmonary tuberculosis patients in East Gojjam Zone, Northwest Ethiopia: a longitudinal study.
    Asemahagn MA.
    BMC Pulm Med; 2021 Apr 08; 21(1):118. PubMed ID: 33832466
    [Abstract] [Full Text] [Related]

  • 36. Rapid laboratory diagnosis of pulmonary tuberculosis.
    Bhirud P, Joshi A, Hirani N, Chowdhary A.
    Int J Mycobacteriol; 2017 Apr 08; 6(3):296-301. PubMed ID: 28776530
    [Abstract] [Full Text] [Related]

  • 37. A novel automatic molecular test for detection of multidrug resistance tuberculosis in sputum specimen: A case control study.
    Li Q, Ou XC, Pang Y, Xia H, Huang HR, Zhao B, Wang SF, Zhao YL.
    Tuberculosis (Edinb); 2017 Jul 08; 105():9-12. PubMed ID: 28610793
    [Abstract] [Full Text] [Related]

  • 38. Comparison of levofloxacin versus moxifloxacin for multidrug-resistant tuberculosis.
    Koh WJ, Lee SH, Kang YA, Lee CH, Choi JC, Lee JH, Jang SH, Yoo KH, Jung KH, Kim KU, Choi SB, Ryu YJ, Chan Kim K, Um S, Kwon YS, Kim YH, Choi WI, Jeon K, Hwang YI, Kim SJ, Lee YS, Heo EY, Lee J, Ki YW, Shim TS, Yim JJ.
    Am J Respir Crit Care Med; 2013 Oct 01; 188(7):858-64. PubMed ID: 23927582
    [Abstract] [Full Text] [Related]

  • 39. Time to sputum culture conversion and treatment outcome among the first cohort of multidrug resistant tuberculosis patients in a high burden country.
    Ige OM, Oladokun RE.
    Indian J Tuberc; 2018 Oct 01; 65(4):322-328. PubMed ID: 30522620
    [Abstract] [Full Text] [Related]

  • 40. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Zhu L, Yang YZ, Guan HY, Cheng SM, Jin YY, Tan WG, Wu QF, Liu XL, Zhao MG, Lu ZH, Jia ZW.
    Int J Tuberc Lung Dis; 2017 Jul 01; 21(7):759-765. PubMed ID: 28633700
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.